Key facts
- Affinity Asset Advisors, LLC filed SCHEDULE 13G/A for Verrica Pharmaceuticals Inc. Common Stock, $0.0001 par value per share (VRCA).
- Disclosed ownership: 5.5%.
- Date of event: 22 Jan 2026.
Affinity Asset Advisors, LLC - 22 Jan 2026 SCHEDULE 13G/A Report for Verrica Pharmaceuticals Inc. Common Stock, $0.0001 par value per share (VRCA)
- Filing Manager
- Affinity Asset Advisors, LLC
- Reporting Manager
- Affinity Asset Advisors, LLC
- Symbol
- VRCA
- Shares outstanding
- 16,075,855 shares
- Disclosed Ownership
- 884,172 shares
- Ownership
- 5.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 29 Jan 2026, 19:59:15 UTC
- Date of event
- 22 Jan 2026
- Previous filing
- 03 Dec 2025
- SEC
- View on sec.gov
Key filing fact
Affinity Asset Advisors, LLC disclosed 5.5% ownership in Verrica Pharmaceuticals Inc. Common Stock, $0.0001 par value per share (VRCA) on 22 Jan 2026.
Change
- Previous schedule filing date: 03 Dec 2025.
- Current filing was accepted on 29 Jan 2026, 19:59.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Affinity Asset Advisors, LLC | 5.5% | 884,172 | 884,172 | 0 | /s/ Andrew Weinstein | Andrew Weinstein, Chief Financial Officer and Chief Compliance Officer | |
| Michael Cho | 5.5% | 884,172 | 884,172 | 0 | /s/ Michael Cho | Michael Cho, Self |
CIK / CUSIP context first